Takeshi Iwata Selected Research

Takeshi Iwata Research Topics

Disease

15	Macular Degeneration (Age-Related Maculopathy) 11/2023 - 04/2003
8	Glaucoma 01/2020 - 08/2004
5	Atrophy 01/2021 - 01/2019
4	Choroidal Neovascularization 11/2023 - 01/2004
3	Cone-Rod Dystrophies 01/2021 - 01/2019
3	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2019 - 01/2014
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 09/2013
3	Retinal Degeneration 01/2018 - 10/2010
3	Open-Angle Glaucoma (Glaucoma, Open Angle) 09/2013 - 11/2003
2	Retinoschisis (Retinoschisis, Juvenile) 01/2023 - 01/2019
2	Genetic Risk Score 12/2022 - 01/2020
2	Low Tension Glaucoma 11/2022 - 11/2003
2	Optic Nerve Diseases (Optic Neuropathy) 01/2020 - 10/2017
2	Hyperthyroidism 06/2004 - 01/2003
1	Polypoidal Choroidal Vasculopathy 11/2023
1	Body Weight (Weight, Body) 11/2022
1	Cataract (Cataracts) 10/2022
1	Retinal Diseases 12/2021
1	Blindness (Hysterical Blindness) 12/2020
1	Retinal Neovascularization 01/2020
1	Retinitis Pigmentosa 2 01/2020
1	Leber Congenital Amaurosis 01/2020
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2020
1	Optic Atrophy 01/2020
1	Choroideremia 01/2019
1	Disease Progression 05/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Color Vision Defects (Color Blindness) 05/2016
1	Retinal Dystrophies 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2014
1	Gliosis 09/2013
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2013
1	Alstrom Syndrome 01/2013
1	Stargardt Disease 05/2011
1	Retinoblastoma (Glioblastoma, Retinal) 02/2007
1	Neoplasms (Cancer) 08/2006

Drug/Important Bio-Agent (IBA)

21	Retinaldehyde (Retinal)IBA 01/2023 - 10/2005
11	Proteins (Proteins, Gene)FDA Link 11/2023 - 10/2005
3	Indicators and Reagents (Reagents)IBA 12/2022 - 01/2019
3	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2005 - 01/2003
3	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2005 - 01/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 05/2018 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 05/2016 - 01/2016
2	Amino Acids FDA Link 01/2013 - 10/2010
2	Complement System Proteins (Complement)IBA 01/2010 - 10/2005
2	Nitroarginine (NG Nitro L Arginine)IBA 01/2005 - 06/2004
2	trabecular meshwork-induced glucocorticoid response proteinIBA 08/2004 - 11/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2004 - 01/2003
1	Peptide Hydrolases (Proteases)FDA Link 11/2023
1	Serine (L-Serine)FDA Link 11/2023
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2022
1	Histones (Histone)IBA 11/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2022
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2021
1	Acyl Carrier ProteinIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Malonyl Coenzyme A (Malonyl CoA)IBA 01/2020
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2020
1	Serine Proteases (Serine Protease)IBA 01/2020
1	Microfilament Proteins (Actin Binding Proteins)IBA 01/2019
1	GTP Phosphohydrolases (GTPases)IBA 01/2019
1	Cytoskeletal ProteinsIBA 01/2019
1	KUS121IBA 05/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	Timolol (Blocadren)FDA LinkGeneric 01/2018
1	diphosphoric acid (pyrophosphoric acid)IBA 01/2018
1	purinoceptor P2Y6IBA 10/2017
1	Ranibizumab (Lucentis)FDA Link 01/2017
1	Cyclic NucleotidesIBA 05/2016
1	Asparaginase (Elspar)FDA Link 01/2016
1	High-Temperature Requirement A Serine Peptidase 1IBA 01/2015
1	NucleotidesIBA 01/2015
1	AntibodiesIBA 09/2014
1	SmokeIBA 09/2014
1	Fibronectins (Fibronectin)IBA 09/2014
1	Apolipoproteins E (ApoE)IBA 01/2014
1	Rhodopsin (Visual Purple)IBA 01/2014
1	ApolipoproteinsIBA 01/2014
1	Mutant Proteins (Protein, Mutant)IBA 09/2013
1	Nonsense Codon (Nonsense Mutation)IBA 01/2013
1	Complement C2 (Complement Component 2)IBA 09/2012
1	Complement Factor B (Factor B)IBA 09/2012
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 05/2011
1	GuanosineIBA 02/2010
1	Guanine NucleotidesIBA 02/2010
1	compstatinIBA 01/2010
1	Peptides (Polypeptides)IBA 01/2010
1	Complement C3 (C3 Complement)IBA 01/2010
1	4-hydroxyhexenalIBA 05/2008
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2008
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 05/2008
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2008
1	Carrier Proteins (Binding Protein)IBA 02/2007
1	tissue-factor-pathway inhibitor 2 (PP5)IBA 02/2007
1	ribosomal protein L11IBA 02/2007
1	E2F3 Transcription FactorIBA 02/2007

Therapy/Procedure

1	Therapeutics 10/2010
1	Intravenous Administration 08/2006